[Skip to Content]
[Skip to Content Landing]
Download PDF
Figure 1.
Age distribution of patients with tuberculous pleural effusion.

Age distribution of patients with tuberculous pleural effusion.

Figure 2.
Correlation between adenosine deaminase (ADA) and ADA2 (top) and interferon gamma (IFN-γ) (bottom).

Correlation between adenosine deaminase (ADA) and ADA2 (top) and interferon gamma (IFN-γ) (bottom).

Figure 3.
Effect of the prevalence of tuberculous pleural effusions on the positive predictive value of a high adenosine deaminase concentration for their diagnosis, given a sensitivity of 100% and a specificity of 95%.

Effect of the prevalence of tuberculous pleural effusions on the positive predictive value of a high adenosine deaminase concentration for their diagnosis, given a sensitivity of 100% and a specificity of 95%.9

Table 1. 
Cytologic and Biochemical Characteristics of Tuberculous Pleural Effusions: Descriptive Statistics*
Cytologic and Biochemical Characteristics of Tuberculous Pleural Effusions: Descriptive Statistics*
Table 2. 
Sensitivity of Each of the Criteria Used for Definitive Diagnosis of Tuberculous Pleurisy
Sensitivity of Each of the Criteria Used for Definitive Diagnosis of Tuberculous Pleurisy
1.
Yamamoto  SDunn  CJWilloughby  DA Studies on delayed hypersensitivity pleural exudates in guinea pigs, II: the interrelationship of monocytic and lymphocytic cells with respect to migration activity. Immunology. 1976;30513- 519
2.
Stead  WWEichenholz  AStauss  HK Operative and pathologic findings in twenty-four patients with syndrome of idiopathic pleurisy with effusion, presumably tuberculous. Am Rev Respir Dis. 1955;71473- 502
3.
Roper  WHWaring  JJ Primary serofibrinous pleural effusion in military personnel. Am Rev Respir Dis. 1955;71616- 634
4.
Valdés  LÁlvarez  DValle  JMPose  ASan José  E The etiology of pleural effusions in an area with high incidence of tuberculosis. Chest. 1996;109158- 162Article
5.
Epstein  DMKline  LRAlbelda  SMMiller  WT Tuberculous pleural effusions. Chest. 1987;91106- 109Article
6.
Valdés  LPose  ASuárez  J  et al.  Cholesterol: a useful parameter for distinguishing between pleural exudates and transudates. Chest. 1991;991097- 1102Article
7.
Valdés  LÁlvarez  DSan José  E  et al.  Value of adenosine deaminase in the diagnosis of tuberculous pleural effusion in young patients in a region of high prevalence of tuberculosis. Thorax. 1995;50600- 603Article
8.
Bueno  CEClemente  GCastro  BC  et al.  Cytologic and bacteriologic analysis of fluid and pleural biopsy specimens with Cope's needle. Arch Intern Med. 1990;1501190- 1194Article
9.
Valdés  LSan José  EÁlvarez  D  et al.  Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme and interferon-gamma. Chest. 1993;103458- 465Article
10.
Valdés  LSan José  EÁlvarez  DValle  JM Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increased ADA in tuberculous pleurisy. Eur Respir J. 1996;9747- 751Article
11.
Fontán  Bueso JVerea Hernando  HPérez García-Buela  JDomínguez Juncal  LMartín Egaña  MTMontero  Martínez MC Diagnostic value of simultaneous determination of pleural adenosine deaminase and pleural lysozyme/serum lysozyme ratio in pleural effusions. Chest. 1988;93303- 307Article
12.
Ribera  EOcaña  IMartínez-Vázquez  JMRossell  MEspañol  TRuibal  A High level of interferon gamma in tuberculous pleural effusion. Chest. 1988;93308- 311Article
13.
Söderblom  TNyberg  PTeppo  AMKlockars  MRiska  HPettersson  T Pleural fluid interferon-γ and tumour necrosis factor-α in tuberculous and rheumatoid pleurisy. Eur Respir J. 1996;91652- 1655Article
14.
Shimokata  KSaka  HMurate  THasegawa  YHasegawa  T Cytokine content in pleural effusion: comparison between tuberculous and carcinomatous pleurisy. Chest. 1991;991103- 1107Article
15.
Yokoyama  AMaruyama  MIto  MKohno  NHiwada  KYano  S Interleukin 6 activity in pleural effusion: its diagnostic value and thrombopoietic activity. Chest. 1992;1021055- 1059Article
16.
Yokoyama  AKohno  NFujino  SAbe  MIshida  OHiwada  K Soluble interleukin-6 receptor levels in pleural effusions. Respir Med. 1996;90329- 332Article
17.
Baganha  MFMota-Pinto  APego  MAMarques  MATSantos Rosa  MARobalo Cordeiro  AJA Neopterin in tuberculous and neoplastic pleural fluids. Lung. 1992;170155- 161Article
18.
Hara  NAbe  MInuzuka  SKawarada  YShigematsu  N Pleural SC5b-9 in differential diagnosis of tuberculous, malignant, and other effusions. Chest. 1992;1021060- 1064Article
19.
Giusti  G Adenosine deaminase. Bergmeyer  HUed.Methods of Enzymatic Analysis New York, NY Academic Press1974;1092- 1099
20.
Giusti  GGakis  C Temperature conversion factor, activation energy, relative substrate specificity and optimum pH of adenosine deaminase from human serum and tissue. Enzyme. 1971;12417- 425
21.
Light  RW Thoracentesis (diagnostic and therapeutic) and pleural biopsy. Light  RWed.Pleural Disease Philadelphia, Pa Lea & Febiger1990;295- 309
22.
Cope  C New pleural biopsy needle. JAMA. 1958;1671107- 1108Article
23.
Abrams  LD New inventions: a pleural biopsy punch. Lancet. 1958;130- 31Article
24.
Grupo de Trabajo Sobre Tuberculosis, Consenso nacional para el control de la tuberculosis en España. Med Clin (Barc). 1992;9824- 31
25.
Vidal  Rde Gracia  JRuiz  JFite  EMonsó  EMartín  N Estudio controlado de 637 pacientes con tuberculosis: diagnóstico y resultados terapéuticos con esquemas de 9 y 6 meses. Med Clin (Barc). 1986;87368- 370
26.
Paterson  HC The pleural reaction to inoculation with tubercle bacilli in vaccinated and normal guinea pigs. Am Rev Tuberculous Pulmon Dis. 1917;1353
27.
Berger  HWMejia  E Tuberculous pleurisy. Chest. 1973;6388- 92Article
28.
Allen  JCApicella  MA Experimental pleural effusion as a manifestation of delayed hypersensitivity to tuberculin PPD. J Immunol. 1968;101481- 487
29.
Wisdrow  ONilsson  BS Pleurisy induced by intrapleural BCG in immunized guinea pigs. Eur J Respir Dis. 1982;63425- 434
30.
Leibowitz  SKennedy  LLessof  MH The tuberculin reaction in the pleural cavity and its suppression by antilymphocyte serum. Br J Exp Pathol. 1973;54152- 162
31.
Ferrer  J Pleural tuberculosis. Eur Respir J. 1997;10942- 947
32.
Seibert  AFHaynes  J  JrMiddleton  RBass  JB  Jr Tuberculous pleural effusions: twenty-year experience. Chest. 1991;99883- 886Article
33.
Moudgil  HSridhar  GLeitch  AG Reactivation disease: the commonest form of tuberculous pleural effusion in Edinburgh, 1980-1991. Respir Med. 1994;88301- 304Article
34.
Light  RW Diagnostic principles in pleural disease. Eur Respir J. 1997;10476- 481Article
35.
Ena  JValls  VPérez de Oteyza  CEnríquez de Salamanca  R Utilidad y limitaciones de la adenosina desaminasa en el diagnóstico de la pleuresía tuberculosa: estudio metaanalítico. Med Clin (Barc). 1990;95333- 335
36.
Bañales  JLPineda  PRFitzgerald  JMRubio  HSelman  MSalazar-Lezama  M Adenosine deaminase in the diagnosis of tuberculous pleural effusions: a report of 218 patients and review of the literature. Chest. 1991;99355- 357Article
37.
Querol  JMBarbe  FManresa  FEsteban  LCañete  C Low value of adenosine deaminase in tuberculous pleural effusions. Eur Respir J. 1990;3586- 587
38.
Gakis  C Adenosine deaminase (ADA) isoenzymes ADA1 and ADA2: diagnostic and biological role. Eur Respir J. 1996;9632- 633Article
39.
Ungerer  JPJOosthuizen  HMBissbort  SHVermaak  WJH Serum adenosine deaminase: isoenzymes and diagnostic application. Clin Chem. 1992;381322- 1326
40.
Ungerer  JPJOosthuizen  HMRetief  JHBissbort  SH Significance of adenosine deaminase activity and its isoenzymes in tuberculous effusions. Chest. 1994;10633- 37Article
41.
Ribera  EMartínez-Vázquez  JMOcaña  I  et al.  Interferón gamma y adenosina desaminasa en las pleuritis. Med Clin (Barc). 1990;94364- 367
42.
Villena  VLópez-Encuentra  AEchave-Sustaeta  JMartín-Escribano  POrtuño-de-Solo  BEstenoz-Alfaro  J Interferon-γ in 388 immunocompromised and immunocompetent patients for diagnosing pleural tuberculosis. Eur Respir J. 1996;92635- 2639Article
43.
Levine  HMetzger  WLacera  DKay  L Diagnosis of tuberculous pleurisy by culture of pleural biopsy specimen. Arch Intern Med. 1970;126269- 271Article
44.
Maartens  GBateman  ED Tuberculous pleural effusions: increased culture yield with bedside inoculation of pleural fluid and poor diagnostic value of adenosine deaminase. Thorax. 1991;4696- 99Article
45.
Sahn  SA The pleura. Am Rev Respir Dis. 1988;138184- 234Article
46.
Tsicopoulos  AQutayba  HVarney  V  et al.  Preferential messenger RNA expression of TH1-type cells (IFN-gamma+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin. J Immunol. 1992;1482058- 2061
47.
Ellner  JJ Pleural fluid and peripheral blood lymphocyte function in tuberculosis. Ann Intern Med. 1978;89932- 933Article
48.
Rossi  GABalbi  BManca  F Tuberculous pleural effusions: evidence for selective presence of PPD-specific T-lymphcytes at site of inflammation in the early phase of the infection. Am Rev Respir Dis. 1987;136575- 579Article
Original Investigation
October 12, 1998

Tuberculous PleurisyA Study of 254 Patients

Author Affiliations

From the Pneumology (Drs Valdés, Álvarez, Penela, Valle, and García-Pazos), Biochemistry (Dr San José), and Internal Medicine (Drs Suárez and Pose) Services, Hospital de Conxo, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.

Arch Intern Med. 1998;158(18):2017-2021. doi:10.1001/archinte.158.18.2017
Abstract

Objectives  To determine the age at which tuberculous pleural effusions occur, the radiological and biochemical characteristics of the effusions, the sensitivities of the various diagnostic tests, and the utility of combining clinical, radiological, and analytic data in diagnosis.

Methods  We studied the case histories of 254 patients in whom tuberculous pleural effusions were diagnosed with certainty between January 1, 1989, and June 30, 1997, in a Spanish university hospital in a region with a high incidence of tuberculosis.

Results  The mean (±SD) age of the patients was 34.1 ± 18.1 years, and 62.2% were younger than 35 years. The effusion was on the right side in 55.9% of patients, on the left side in 42.5% of patients, and on both sides in 1.6% of patients. In 81.5% of patients, less than two thirds of the hemithorax was affected. Associated pulmonary lesions were detected in 18.9% of patients, of whom 14.6% exhibited cavitation. In 93.3% of the effusions, more than 50% of leukocytes were lymphocytes, and almost all had the biologic characteristics of exudates (98.8% had high total protein contents, 94.9% had high cholesterol levels, and 82.3% had high lactate dehydrogenase levels). All but 1 effusion (99.6%) had an adenosine deaminase (ADA) concentration higher than 47 U/L, 96.8% (123/127) of the effusions had high ADA2 levels, and 89% (73/82) of the effusions had high interferon gamma levels. Adenosine deaminase 2 contributed 72.2% ± 12.5% (mean ± SD) of total ADA activity. Total ADA activity was significantly correlated with ADA2 (r=0.83) and with interferon gamma (r=0.30) levels. Definitive diagnosis was based on the observation of caseous granulomas in pleural biopsy tissue samples in 79.8% of patients, on the results of biopsy cultures in 11.7% of patients, and on pleural effusion cultures in the remaining 8.5% of patients. Results of the tuberculin skin test were positive in only 66.5% of patients.

Conclusions  In these patients, lymphocyte-rich exudative pleural effusions occurred, on average, at a young age, with no preference for either the right or the left side; normally affected no more than two thirds of the hemithorax; and were generally unaccompanied by pulmonary infiltrates. High ADA concentration was a highly sensitive diagnostic sign and was caused by a rise in ADA2 concentration. The most sensitive criterion based on pleural biopsy was the observation of caseous granulomas, and culture of biopsy material further increased overall sensitivity. Negative skin test results were no guarantee of the effusion being nontuberculous. This, together with the low mean age of the patients and the low frequency of associated pulmonary lesions, suggests that tuberculous pleural effusion is a primary form of tuberculosis in this region.

MYCOBACTERIUM tuberculosis invades the pleural cavity chiefly through rupture of subpleural caseous foci within 6 to 12 weeks after a primary infection. Bacillus protein antigens seem to induce a delayed hypersensitivity reaction that stimulates lymphocytes, which in turn release certain lymphokines that (1) activate macrophages against the mycobacterium and (2) alter the permeability of pleural vessels and affect the formation of granulomas.1 Tuberculous pleural effusion (TPE) is an acute granulomatous pleurisy caused by recent infection by the mycobacterium. Patients with TPE invariably have a small subpleural nidus of tuberculosis showing fibrous and granulomatous inflammation and clear signs of leakage into the pleural space.2 Although TPE can resolve spontaneously within a few weeks or months, about one third of persons with untreated TPE subsequently develop a more serious form of tuberculosis.3 In our region (Galicia, in the northwest part of Spain), TPE chiefly affects young adults and children,4 radiologically has no preference for either the right or the left side,5 and is generally unaccompanied by pulmonary lesions.

Tuberculous pleural effusions are not always easy to diagnose because the standard criterion (the presence of a lymphocyte-rich exudate associated with caseous necrotic granulomas in pleural biopsy tissue samples, positive Ziehl-Neelsen stains or Lowenstein cultures of effusion or tissue samples, and cutaneous sensitivity to purified tuberculin protein antigen derivative [PPD]) is not invariably satisfied.68 In recent years, numerous authors studied possible biochemical markers such as adenosine deaminase (ADA), ADA isoenzymes, lysozyme, interferon gamma (IFN-γ), and other lymphokines918 to improve diagnostic efficiency, but diagnosis is still sometimes difficult.

In this article, we review all the case histories of patients with TPE who have been diagnosed with certainty in our center during the past 8 years. Our aim was to determine (1) the age at which the effusion occurs, (2) the most common radiological signs, (3) the biochemical characteristics of the effusion, (4) the sensitivities of the various diagnostic tests, and (5) the utility of certain combinations of clinical, radiological, and analytic data for diagnosis.

PATIENTS, MATERIALS, AND METHODS

We studied the case histories of all 254 patients in whom TPE was diagnosed with certainty in our center between January 1, 1989, and June 30, 1997. Pleural effusions were diagnosed as tuberculous if (1) caseous necrotic granulomas were found in pleural biopsy tissue samples, (2) Ziehl-Neelsen stains or Lowenstein cultures of effusion or biopsy tissue samples were positive, or (3) Ziehl-Neelsen stains or Lowenstein cultures of sputum samples were positive if the pleural effusion was accompanied by pulmonary infiltration. All possible cases that failed to satisfy one of these criteria were excluded from the study. In no case was definitive diagnosis arrived at via thoracoscopy or open lung biopsy.

The following variables or procedures were recorded for or performed in all patients: patient age and sex; risk factors for tuberculosis; posteroanterior and lateral chest radiography; concentrations of protein, lactate dehydrogenase, cholesterol, and ADA in pleural fluid; Ziehl-Neelsen stains and Lowenstein cultures of pleural fluid; and tuberculin skin tests. In addition, the cytologic features of pleural fluid (total leukocyte count and percentage of lymphocytes) were determined in 230 patients; pleural fluid ADA2 and IFN-γ levels were determined in 127 and 82 patients, respectively; pleural biopsy tissue samples were investigated by Ziehl-Neelsen staining, Lowenstein cultures, and histological examination in 248 patients (the other 6 patients had empyema); and sputum samples were studied by Ziehl-Neelsen staining and Lowenstein culture in 48 patients in whom pleural effusion was associated with pulmonary lesions.

Pleural effusions were deemed slight if they affected less than one third of the hemithorax, moderate if they affected between one third and two thirds of the hemithorax, and massive if they affected more than two thirds of the hemithorax. Protein (in grams per liter), lactate dehydrogenase (in units per liter), and cholesterol (in millimoles per liter [milligrams per deciliter]) levels were determined by methods described elsewhere,6 as was IFN-γ level (in picograms per milliliter).9 Adenosine deaminase activity (in units per liter) was determined by the Giusti method,19 and ADA2 activity (in units per liter) was calculated from the activities of ADA and 2′-deoxyadenosine deaminase and the known affinities of ADA2 for adenosine and 2′-deoxyadenosine.20 Thoracocentesis was performed as usual21 and, except in patients in whom macroscopic findings suggested empyema, was followed by pleural biopsy with Cope22 or Abrams23 needles. Tuberculin skin tests were effected by intradermal injection of 0.1 mL of PPD containing 2 units of PPD RT-23; tests were read 48 to 72 hours later, and results were deemed positive if an induration of 5 mm or more in diameter was observed.24 No other tests for anergy were performed.

Results were analyzed statistically after previous verification that continuous variables were normally distributed. Interferon gamma concentrations were subjected to logarithmic transformation to normalize their distribution. Correlations were quantified by means of the Pearson correlation coefficient. Differences were considered significant at P<.05 in all statistical tests. The values of the biochemical markers that were used as diagnostic thresholds were those identified as optimal for this purpose in previous studies.6,9,10

RESULTS

The 254 patients with TPE comprised 154 men and 100 women, with a mean (±SD) age of 34.1 ± 18.1 years (35.7 ± 18.6 years for men and 31.5 ± 17.0 years for women); Figure 1 shows their distribution by age group. Approximately 158 (62.2%) of 254 patients were younger than 35 years. Risk factors for tuberculosis were detected in 49 patients (19.3%) as follows: alcoholism, 38 patients; human immunodeficiency virus, 4 patients; neoplasia, 4 patients; psychiatric disorders, 2 patients; and hepatic cirrhosis, 1 patient.

Radiological test results showed effusions on the right side in 142 patients (55.9%), on the left side in 108 patients (42.5%), and on both sides in 4 patients (1.6%). The effusion affected more than two thirds of the hemithorax in 47 patients (18.5%), between one third and two thirds of the hemithorax in 120 patients (47.2%), and less than one third of the hemithorax in 87 patients (34.2%). In 48 patients (18.9%), pleural effusion was associated with pulmonary lesions, which were in the right upper lobe in 20 patients, the left upper lobe in 17 patients, the right lower lobe in 5 patients, the left lower lobe in 5 patients, and the middle lobe in 1 patient; 7 (14.6%) of these 48 patients exhibited pulmonary cavitation.

Table 1 lists the cytologic and biochemical characteristics of the effusions. In 237 patients (93.3%), more than 50% of leukocytes were lymphocytes; in 241 patients (94.9%), cholesterol concentration was at least 1.42 mmol/L (55 mg/dL); in 251 patients (98.8%), protein concentration was at least 30 g/L; in 209 patients (82.3%), lactate dehydrogenase activity was at least 200 U/L; and in 253 patients (99.6%), ADA activity exceeded the diagnostic threshold of 47 U/L. In 123 (96.8%) of 127 patients in whom ADA2 activity was determined, the value was at least 40 U/L; and in 73 (89%) of 82 patients in whom IFN-γ level was determined, the value was at least 140 pg/mL. Adenosine deaminase 2 contributed 72.2% ± 12.5% (mean ± SD) of total ADA activity (median, 71.4%; range, 25%-94%). Adenosine deaminase activity was significantly correlated with ADA2 activity (r=0.83; P=.000; n=127; Figure 2, top) and with IFN-γ level (r=0.30; P =.005; n=82; Figure 2, bottom).

Table 2 lists the microbiologic and histological findings. By the definition of the study group, in all patients at least 1 of these tests had a positive result. The joint sensitivity of the analyses of biopsy tissue samples was 91.5% (227 of 248 patients), and that of pleural fluid sample analyses was 36.6% (93 of 254 patients). The most frequent finding (198 [79.8%] of 248 patients) was the observation of caseating granulomas in biopsy tissue samples. Of the 48 patients in whom the lung was affected, 30 (62.5%) had positive Ziehl-Neelsen sputum stains and all had positive Lowenstein sputum cultures.

Results of the tuberculin skin test were positive in 169 (66.5%) of 254 patients.

COMMENT

In Spain, the pleura is affected in 23.3% of all patients with tuberculosis,25 and in our hospital, tuberculosis is the most common cause (25%) of pleural effusions among patients cared for in the pneumology and internal medicine services.4

Since early this century,26 it has been recognized that tuberculous pleurisy is a delayed hypersensitivity reaction rather than an infection of the pleura. Cultures of pleural tissue and fluid from patients with tuberculous pleurisy are often negative,27 and in guinea pigs and mice, intrapleural injection of PPD 3 to 5 weeks after priming with a suspension of dead bacilli causes an exudative pleural effusion within 12 to 48 hours,28,29 whereas no such effusion is induced in sensitized animals by administration of antilymphocyte serum.30 Once mycobacterial protein enters the pleural cavity, there occurs a series of insufficiently elucidated immunologic reactions that give rise to the effusion.31

Tuberculous pleurisy was once considered generally to be a primary form of tuberculosis because it usually occurred in children and young adults in whom tuberculin skin test results had only recently been positive rather than negative. In recent years, several authors reported that mean patient age has gradually risen5,32,33 and that tuberculous pleurisy is becoming a predominantly reactivated form of tuberculosis, at least in industrialized nations. In this study, the mean (±SD) age at occurrence was 34.1 ± 18.1 years, which is similar to that in previous studies4,6,9,10 and considerably less than that reported by the authors mentioned above.5,32,33 Although this study was not designed to classify tuberculous pleurisy as primary or reactivated tuberculosis, the low mean patient age, together with the low association with pulmonary lesions, suggests that, in our region, tuberculous pleurisy is still a primary tuberculosis.

Patient age is also of great diagnostic importance because in young patients the presence of a pleural exudate with a high ADA concentration and a majority of lymphocytes among its leukocytes is highly suggestive of tuberculosis to the extent that pleural biopsy may be superfluous.7 The diagnosis of tuberculous pleurisy in older patients is more problematic because of the higher incidence of clinically similar disorders, neoplastic effusions in particular.

The determination of ADA activity in pleural fluid samples is now recognized as obligatory for characterization of a pleural exudate31,34 given its utility for the diagnosis of TPE.9 In our region, this marker of tuberculous pleurisy has a sensitivity of 100% and a specificity of between 91%10 and 95%.9 Ena et al35 obtained similar figures (a sensitivity of 99% and a specificity of 93%) in a meta-analytic study. The results of the present study are in keeping with these high reported sensitivities. Furthermore, as noted above, in our region, the presence of a pleural exudate with a high ADA concentration and a majority of lymphocytes among its leukocytes makes pleural biopsy unnecessary if the patient is young (<35 years). This is partly because of the high prevalence of tuberculous pleuritis in this region, which increases the positive predictive value and efficiency of ADA concentration as a diagnostic marker (Figure 3)9; in other regions, the efficiency of this marker will not necessarily be as high, and clinicians are accordingly advised to determine this variable for their own region.36

One of our patients, aged 58 years, had an ADA concentration of only 22 U/L on first determination; but, on redetermination in a second sample, this figure rose to 62 U/L. Similar behavior was reported by Querol et al37: of 9 patients with tuberculous pleurisy with subthreshold ADA concentrations on first determination, 5 had high levels on second determination.

Adenosine deaminase comprises 2 isoenzymes: ADA1, which is found in all cells, and ADA2, which is found only in monocytes and macrophages.38 That the high ADA activity in patients with TPE is largely caused by ADA2 is corroborated by our findings that ADA2 contributed 72.2% ± 12.5% (mean ± SD) of total ADA activity in the 127 effusions in which it was determined, and that ADA and ADA2 were significantly correlated (r=0.83; P =.000); this high ADA2 activity is caused by increased production by monocytes and macrophages that have been stimulated by live phagocytosed microorganisms.39 Our results also confirm previous findings10,40 in showing that ADA2, like total ADA activity, is a sensitive marker of tuberculous pleurisy, with 96.8% (123/127) of the effusions in this study having ADA2 concentrations higher than the diagnostic threshold of 40 U/L.

Interferon gamma is a lymphokine released by sensitized CD4+ lymphocytes. It increases the mycobactericidal activity of macrophages and has proved to be a useful marker for diagnosis of tuberculous pleurisy.9,1214,41,42 In the first studies of IFN-γ in this role,12,41 its sensitivity and specificity for tuberculous pleurisy were both 100%. In an earlier study9 of this lymphokine, its sensitivity and specificity were 94.2% and 91.8%, respectively, 2 TPEs having low IFN-γ concentrations and 9 pleural effusions of other kinds having high IFN-γ concentrations; in this study, its sensitivity was even lower, 89% (73 of 82 patients). Other authors also reported cases of low IFN-γ levels in TPEs13,42 and high concentrations in neoplastic effusions,14,42 parapneumonic effusions,42 and non-TPEs of unknown cause.42 Further research is necessary to clarify the cause of high IFN-γ levels in non-TPEs. The fact that in this study the 9 TPEs with subthreshold IFN-γ levels all affected less than one third of the hemithorax recalls reports of TPEs of small extent being associated with IFN-γ concentrations only slightly above the diagnostic threshold.12 It would seem that the production of lymphokines by sensitized CD4+ lymphocytes must be low in such cases. In this study, results of the Mantoux test were also negative in 5 of 9 patients with subthreshold IFN-γ levels.

Although the rises in ADA and IFN-γ levels in TPE have different origins (infected macrophages in the case of ADA and sensitized CD4+ cells in that of IFN-γ), in this study, although not in certain others,9,14,41 ADA and IFN-γ were correlated. This, together with the fact that the IFN-γ level is much more expensive to determine than the ADA level, suggests that determination of the IFN-γ level is not justified for routine characterization of pleural effusions.

The sensitivities of the methods used for definitive diagnosis were similar to those reported in earlier studies.7,27,43 In particular, the joint sensitivity of the methods requiring pleural biopsy was 91.5%, similar to previously reported figures43,44: caseating granulomas were observed in 79.8% (198/248) of patients, but Lowenstein culture allowed diagnosis in a further 29 patients. Thus, in general, pleural biopsy is the procedure affording the best chance of diagnosis.45

Results of the tuberculin skin test were negative in 33.5% (85/254) of patients . Although similar results have been published previously,27 this is nevertheless a significant finding because the response to PPD in the dermis is mediated, as in the pleura, by interleukin 2 and IFN-γ46 (both produced by CD4+ cells), and IFN-γ levels were generally high in the pleural fluid of our patients. In 1 study,47 the response of circulating T cells to tuberculin was stifled by adherent suppressor cells. Negative skin test results can also be caused by the sequestration of helper and suppressor T cells in the pleural cavity.48

To sum up, we conclude that in our region, (1) the mean age of patients with tuberculous pleurisy is still low (<35 years); (2) there is no tendency for TPE to occur preferentially on either the right or the left side, and bilateral effusions are rare; (3) only about one fifth of patients suffer massive effusions; (4) the effusions have the biochemical characteristics of exudates and a majority of their leukocytes are lymphocytes; (5) ADA is a highly sensitive diagnostic marker of TPE because of increased ADA2 activity, with which it correlates well; (6) the most sensitive diagnostic criterion was the observation of caseating granulomas in biopsy tissue samples, but the joint sensitivity of this criterion and that of positive Lowenstein cultures was significantly higher; (7) a negative tuberculin skin test result does not rule out tuberculous pleurisy; and (8) the low mean age of patients, low radiological prevalence of pulmonary infiltrates, and high proportion of negative tuberculin skin test results suggest that tuberculous pleurisy is still a primary form of tuberculosis.

Back to top
Article Information

Accepted for publication January 12, 1998.

Reprints: Luis Valdés, MD, C/. Emilia Pardo Bazán 26, Urbanización Parque Montouto, 15894 Teo, La Coruña, Spain.

References
1.
Yamamoto  SDunn  CJWilloughby  DA Studies on delayed hypersensitivity pleural exudates in guinea pigs, II: the interrelationship of monocytic and lymphocytic cells with respect to migration activity. Immunology. 1976;30513- 519
2.
Stead  WWEichenholz  AStauss  HK Operative and pathologic findings in twenty-four patients with syndrome of idiopathic pleurisy with effusion, presumably tuberculous. Am Rev Respir Dis. 1955;71473- 502
3.
Roper  WHWaring  JJ Primary serofibrinous pleural effusion in military personnel. Am Rev Respir Dis. 1955;71616- 634
4.
Valdés  LÁlvarez  DValle  JMPose  ASan José  E The etiology of pleural effusions in an area with high incidence of tuberculosis. Chest. 1996;109158- 162Article
5.
Epstein  DMKline  LRAlbelda  SMMiller  WT Tuberculous pleural effusions. Chest. 1987;91106- 109Article
6.
Valdés  LPose  ASuárez  J  et al.  Cholesterol: a useful parameter for distinguishing between pleural exudates and transudates. Chest. 1991;991097- 1102Article
7.
Valdés  LÁlvarez  DSan José  E  et al.  Value of adenosine deaminase in the diagnosis of tuberculous pleural effusion in young patients in a region of high prevalence of tuberculosis. Thorax. 1995;50600- 603Article
8.
Bueno  CEClemente  GCastro  BC  et al.  Cytologic and bacteriologic analysis of fluid and pleural biopsy specimens with Cope's needle. Arch Intern Med. 1990;1501190- 1194Article
9.
Valdés  LSan José  EÁlvarez  D  et al.  Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme and interferon-gamma. Chest. 1993;103458- 465Article
10.
Valdés  LSan José  EÁlvarez  DValle  JM Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increased ADA in tuberculous pleurisy. Eur Respir J. 1996;9747- 751Article
11.
Fontán  Bueso JVerea Hernando  HPérez García-Buela  JDomínguez Juncal  LMartín Egaña  MTMontero  Martínez MC Diagnostic value of simultaneous determination of pleural adenosine deaminase and pleural lysozyme/serum lysozyme ratio in pleural effusions. Chest. 1988;93303- 307Article
12.
Ribera  EOcaña  IMartínez-Vázquez  JMRossell  MEspañol  TRuibal  A High level of interferon gamma in tuberculous pleural effusion. Chest. 1988;93308- 311Article
13.
Söderblom  TNyberg  PTeppo  AMKlockars  MRiska  HPettersson  T Pleural fluid interferon-γ and tumour necrosis factor-α in tuberculous and rheumatoid pleurisy. Eur Respir J. 1996;91652- 1655Article
14.
Shimokata  KSaka  HMurate  THasegawa  YHasegawa  T Cytokine content in pleural effusion: comparison between tuberculous and carcinomatous pleurisy. Chest. 1991;991103- 1107Article
15.
Yokoyama  AMaruyama  MIto  MKohno  NHiwada  KYano  S Interleukin 6 activity in pleural effusion: its diagnostic value and thrombopoietic activity. Chest. 1992;1021055- 1059Article
16.
Yokoyama  AKohno  NFujino  SAbe  MIshida  OHiwada  K Soluble interleukin-6 receptor levels in pleural effusions. Respir Med. 1996;90329- 332Article
17.
Baganha  MFMota-Pinto  APego  MAMarques  MATSantos Rosa  MARobalo Cordeiro  AJA Neopterin in tuberculous and neoplastic pleural fluids. Lung. 1992;170155- 161Article
18.
Hara  NAbe  MInuzuka  SKawarada  YShigematsu  N Pleural SC5b-9 in differential diagnosis of tuberculous, malignant, and other effusions. Chest. 1992;1021060- 1064Article
19.
Giusti  G Adenosine deaminase. Bergmeyer  HUed.Methods of Enzymatic Analysis New York, NY Academic Press1974;1092- 1099
20.
Giusti  GGakis  C Temperature conversion factor, activation energy, relative substrate specificity and optimum pH of adenosine deaminase from human serum and tissue. Enzyme. 1971;12417- 425
21.
Light  RW Thoracentesis (diagnostic and therapeutic) and pleural biopsy. Light  RWed.Pleural Disease Philadelphia, Pa Lea & Febiger1990;295- 309
22.
Cope  C New pleural biopsy needle. JAMA. 1958;1671107- 1108Article
23.
Abrams  LD New inventions: a pleural biopsy punch. Lancet. 1958;130- 31Article
24.
Grupo de Trabajo Sobre Tuberculosis, Consenso nacional para el control de la tuberculosis en España. Med Clin (Barc). 1992;9824- 31
25.
Vidal  Rde Gracia  JRuiz  JFite  EMonsó  EMartín  N Estudio controlado de 637 pacientes con tuberculosis: diagnóstico y resultados terapéuticos con esquemas de 9 y 6 meses. Med Clin (Barc). 1986;87368- 370
26.
Paterson  HC The pleural reaction to inoculation with tubercle bacilli in vaccinated and normal guinea pigs. Am Rev Tuberculous Pulmon Dis. 1917;1353
27.
Berger  HWMejia  E Tuberculous pleurisy. Chest. 1973;6388- 92Article
28.
Allen  JCApicella  MA Experimental pleural effusion as a manifestation of delayed hypersensitivity to tuberculin PPD. J Immunol. 1968;101481- 487
29.
Wisdrow  ONilsson  BS Pleurisy induced by intrapleural BCG in immunized guinea pigs. Eur J Respir Dis. 1982;63425- 434
30.
Leibowitz  SKennedy  LLessof  MH The tuberculin reaction in the pleural cavity and its suppression by antilymphocyte serum. Br J Exp Pathol. 1973;54152- 162
31.
Ferrer  J Pleural tuberculosis. Eur Respir J. 1997;10942- 947
32.
Seibert  AFHaynes  J  JrMiddleton  RBass  JB  Jr Tuberculous pleural effusions: twenty-year experience. Chest. 1991;99883- 886Article
33.
Moudgil  HSridhar  GLeitch  AG Reactivation disease: the commonest form of tuberculous pleural effusion in Edinburgh, 1980-1991. Respir Med. 1994;88301- 304Article
34.
Light  RW Diagnostic principles in pleural disease. Eur Respir J. 1997;10476- 481Article
35.
Ena  JValls  VPérez de Oteyza  CEnríquez de Salamanca  R Utilidad y limitaciones de la adenosina desaminasa en el diagnóstico de la pleuresía tuberculosa: estudio metaanalítico. Med Clin (Barc). 1990;95333- 335
36.
Bañales  JLPineda  PRFitzgerald  JMRubio  HSelman  MSalazar-Lezama  M Adenosine deaminase in the diagnosis of tuberculous pleural effusions: a report of 218 patients and review of the literature. Chest. 1991;99355- 357Article
37.
Querol  JMBarbe  FManresa  FEsteban  LCañete  C Low value of adenosine deaminase in tuberculous pleural effusions. Eur Respir J. 1990;3586- 587
38.
Gakis  C Adenosine deaminase (ADA) isoenzymes ADA1 and ADA2: diagnostic and biological role. Eur Respir J. 1996;9632- 633Article
39.
Ungerer  JPJOosthuizen  HMBissbort  SHVermaak  WJH Serum adenosine deaminase: isoenzymes and diagnostic application. Clin Chem. 1992;381322- 1326
40.
Ungerer  JPJOosthuizen  HMRetief  JHBissbort  SH Significance of adenosine deaminase activity and its isoenzymes in tuberculous effusions. Chest. 1994;10633- 37Article
41.
Ribera  EMartínez-Vázquez  JMOcaña  I  et al.  Interferón gamma y adenosina desaminasa en las pleuritis. Med Clin (Barc). 1990;94364- 367
42.
Villena  VLópez-Encuentra  AEchave-Sustaeta  JMartín-Escribano  POrtuño-de-Solo  BEstenoz-Alfaro  J Interferon-γ in 388 immunocompromised and immunocompetent patients for diagnosing pleural tuberculosis. Eur Respir J. 1996;92635- 2639Article
43.
Levine  HMetzger  WLacera  DKay  L Diagnosis of tuberculous pleurisy by culture of pleural biopsy specimen. Arch Intern Med. 1970;126269- 271Article
44.
Maartens  GBateman  ED Tuberculous pleural effusions: increased culture yield with bedside inoculation of pleural fluid and poor diagnostic value of adenosine deaminase. Thorax. 1991;4696- 99Article
45.
Sahn  SA The pleura. Am Rev Respir Dis. 1988;138184- 234Article
46.
Tsicopoulos  AQutayba  HVarney  V  et al.  Preferential messenger RNA expression of TH1-type cells (IFN-gamma+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin. J Immunol. 1992;1482058- 2061
47.
Ellner  JJ Pleural fluid and peripheral blood lymphocyte function in tuberculosis. Ann Intern Med. 1978;89932- 933Article
48.
Rossi  GABalbi  BManca  F Tuberculous pleural effusions: evidence for selective presence of PPD-specific T-lymphcytes at site of inflammation in the early phase of the infection. Am Rev Respir Dis. 1987;136575- 579Article
×